.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Medtronic
Boehringer Ingelheim
Deloitte
Chubb
Federal Trade Commission
Moodys
Fish and Richardson
Novartis
Dow

Generated: June 27, 2017

DrugPatentWatch Database Preview

MAXITROL Drug Profile

« Back to Dashboard

Which patents cover Maxitrol, and when can generic versions of Maxitrol launch?

Maxitrol is a drug marketed by Novartis Pharms Corp and Sandoz Inc and is included in three NDAs.

The generic ingredient in MAXITROL is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.

Summary for Tradename: MAXITROL

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list66
Clinical Trials: see list2
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MAXITROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
MAXITROL
dexamethasone; neomycin sulfate; polymyxin b sulfate
SUSPENSION/DROPS;OPHTHALMIC050023-002Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe
Sandoz Inc
MAXITROL
dexamethasone; neomycin sulfate; polymyxin b sulfate
SUSPENSION/DROPS;OPHTHALMIC062341-001May 22, 1984ATRXNoNo► Subscribe► Subscribe
Novartis Pharms Corp
MAXITROL
dexamethasone; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC050065-002Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Baxter
Novartis
Merck
Cipla
Fish and Richardson
Boehringer Ingelheim
Moodys
Covington
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot